The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Patient-Reported Costs of Chronic Urticaria in Portugal: A Study of Its Economic Impact

  • By

  • Pedro S. Coelho

  • Jorge M. Mendes

  • João Maia Silva

  • October 14, 2026

Share

Clinical Report: Patient-Reported Costs of Chronic Urticaria in Portugal: A Study of Its Economic Impact

Related Resources & Content

  1. MDSpire News — Spontaneous Urticaria Carries Greater Burden, Costs
  2. Drugs - Real World Outcomes — The Financial and Societal Impact of Pulmonary Arterial Hypertension in Italy: An Analysis of Healthcare Costs
  3. Dermatology and Therapy — Chronic Spontaneous Urticaria (CSU) in Chinese Patients: Real-World Evidence of Disease Control and Treatment Patterns from the Urticaria Voices Study
  4. Clinical Rheumatology — Economic Burden in the First Year Post-Diagnosis for Two Patient Cohorts with Early Rheumatoid Arthritis, Assessed a Decade Apart
  5. The International Guideline for the Definition, Classification, Diagnosis and Management of Urticaria - Zuberbier - 2026 - Allergy - Wiley Online Library
  6. Remibrutinib in Chronic Spontaneous Urticaria - PubMed
  7. The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study - Universidade NOVA de Lisboa

Original Source(s)

The Economic Burden of Chronic Urticaria in Portugal: A Patient-Reported Cost-of-Illness Study

  • by Pedro S. Coelho, Jorge M. Mendes, João Maia Silva

  • October 14, 2026

Related Content

Topical Delgocitinib for Capecitabine-Induced Hand–Foot Syndrome: A Therapeutic Option?

Alopecia therapy gains FDA breakthrough status

The designation covers an investigational botanical treatment for moderate-to-severe alopecia areata in patients aged 2 years and older.

Invasive Group A Streptococcus Toxic Shock Syndrome, Myositis, and Probable Necrotizing Fasciitis in Pemphigus Vulgaris

  • October 6, 2026